Quest Diagnostics Inc vs TORM plc — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while TORM plc trades at $28.3 (market cap $2.93B). The key difference: Quest Diagnostics Inc is far larger — about 8.9× TORM plc's market cap, and TORM plc pays the higher dividend (9.77%). Which is the better fit depends on your goals.
| DGX | TRMD | |
|---|---|---|
Market Cap | $26.21B | $2.93B |
Sector | Health | Technology |
52-Week High | $238.50 | $34.87 |
52-Week Low | $173.49 | $18.77 |
Enterprise Value | $31.97B | $3.82B |
Dividend Yield | 1.45% | 9.77% |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →